Alessandro Moretta,Emanuela Marcenaro,Francois Romagne,Pascale Andre
申请号:
US11720553
公开号:
US08993319B2
申请日:
2005.12.27
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention relates to methods of treating immune disorders, particularly autoimmune or inflammatory disorders, and methods of producing antibodies and other compounds for use in therapeutic strategies for treating such disorders. Generally, the present methods involve the use of antibodies or other compounds that prevent the stimulation of NKG2A receptors on NK cells, leading to the lysis of dendritic cells that contribute to the pathology of the disorders.